Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-FOLR1 Antibody (1J730) is an antibody targeting FOLR1. Anti-FOLR1 Antibody (1J730) can be used in ELISA.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 μL | $209 | 7-10 days | |
100 μL | $348 | 7-10 days |
Description | Antibody Type: Recombinant Monoclonal Application: ELISA Reactivity: Human, Cynomolgus |
Alias | MOv18, KB cells FBP, FR-α, FR-alpha, FR α, FR alpha, FOLR1, FOLR, Folbp1, Folate receptor α, Folate receptor alpha, Folate receptor 1, FBP1, FBP |
Ig Type | hIgG1 |
Clone | 1J730 |
Reactivity | Human, Cynomolgus |
Verified Activity | 1. The Binding Activity of Cynomolgus FOLR1 with Anti-FOLR1 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Cynomolgus FOLR1 at 2 μg/mL can bind Anti-FOLR1 recombinant antibody. The EC50 is 2.900-3.544 ng/mL. 2. The Binding Activity of Cynomolgus FOLR1 with Anti-FOLR1 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Cynomolgus FOLR1 at 2 μg/mL can bind Anti-FOLR1 recombinant antibody. The EC50 is 2.900-3.544 ng/mL. 3. The Binding Activity of Human FOLR1 with Anti-FOLR1 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized human FOLR1 at 2 μg/mL can bind Anti-FOLR1 recombinant antibody. The EC50 is 6.893-7.883 ng/mL. |
Application | ELISA |
Recommended Dose | ELISA:1:5000-1:50000. |
Antibody Type | Monoclonal |
Construction | Recombinant Antibody |
Purification | Affinity-chromatography |
Appearance | Liquid |
Formulation | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
Conjucates | Unconjugated |
Immunogen | Recombinant Protein: Human FOLR1 Protein |
Antigen Species | Human |
Uniprot ID | |
Biology Area | Tags & Cell Markers |
Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.